| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,064 | 0,095 | 06.02. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.01. | Ventripoint Diagnostics Ltd (2): Ventripoint 10,097,720-share private placement | 2 | Stockwatch | ||
| 28.01. | Ventripoint Diagnostics Ltd (2): Ventripoint issues 4.27M shares for debt of $427,696 | 1 | Stockwatch | ||
| 28.01. | Stocks in Play: Ventripoint Diagnostics Ltd | 1 | Baystreet.ca | ||
| VENTRIPOINT DIAGNOSTICS Aktie jetzt für 0€ handeln | |||||
| 28.01. | Ventripoint Diagnostics Ltd.: Ventripoint Issues Shares for Debt Settlement and Awards Option Grants | 1 | TheNewswire | ||
| 26.01. | Ventripoint Diagnostics Ltd (2): Ventripoint Diagnostics 4,276,964 shares for debt | 2 | Stockwatch | ||
| 20.01. | Ventripoint Diagnostics Ltd (2): Ventripoint Diagnostics closes $1-million financing | 1 | Stockwatch | ||
| 19.01. | Ventripoint Diagnostics Ltd.: Ventripoint Announces Closing of Non-Brokered Units Private Placement | 2 | TheNewswire | ||
| 16.01. | Stocks in Play: Ventripoint Diagnostics Ltd | - | Baystreet.ca | ||
| 16.01. | Ventripoint Diagnostics Ltd (2): Ventripoint issues shares to pay debenture interest | 1 | Stockwatch | ||
| 16.01. | Ventripoint Diagnostics Ltd.: Ventripoint Issues Shares for Payment of Debenture Interest | 2 | TheNewswire | ||
| 12.01. | Ventripoint Diagnostics Ltd (2): Ventripoint Diagnostics 1,145,627 shares for debt | 1 | Stockwatch | ||
| 08.01. | Stocks in Play: Ventripoint Diagnostics Ltd | 1 | Baystreet.ca | ||
| 08.01. | Ventripoint Diagnostics Ltd (2): Ventripoint increases financing to $1-million | 2 | Stockwatch | ||
| 07.01. | Ventripoint Diagnostics Ltd.: Ventripoint Doubles the Size of Private Placement Due to Strong Investor Demand | 1 | TheNewswire | ||
| 30.12.25 | Ventripoint Diagnostics Ltd.: Ventripoint Announces Non-Brokered Units Private Placement | 1 | TheNewswire | ||
| 18.12.25 | Ventripoint Diagnostics Ltd.: Ventripoint Diagnostics Announces Collaboration with Summit Sciences | 1 | TheNewswire | ||
| 18.12.25 | Ventripoint Diagnostics Ltd (2): Ventripoint to issue 1.1M shares for debenture interest | 1 | Stockwatch | ||
| 18.12.25 | Ventripoint Diagnostics Ltd.: Ventripoint to Issue Shares for Payment of Debenture Interest | 1 | TheNewswire | ||
| 16.12.25 | Ventripoint Diagnostics Ltd (2): Ventripoint $567,000 debenture private placement | 1 | Stockwatch | ||
| 12.12.25 | Stocks in Play: Ventripoint Diagnostics Ltd | 1 | Baystreet.ca |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ATOSSA THERAPEUTICS | 0,001 | -100,00 % | XFRA NEW INSTRUMENTS AVAILABLE ON 02.02.2026 | The following instruments on XETRA do have their first trading 02.02.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 02.02.2026
Aktien
1 CA00249P1053 AXA S.A. CDR
2 ARP125991090... ► Artikel lesen | |
| TANDEM DIABETES | 16,270 | +0,34 % | Breaking Down Tandem Diabetes Care: 12 Analysts Share Their Views | ||
| MOLINA HEALTHCARE | 107,80 | -3,28 % | Healthcare-Wette von Burry: Molina Healthcare stürzt brutal ab: Was bedeutet der Crash für Anleger? | © Foto: DallE - OpenAISchock-Meldung: Molina Healthcare stürzt um 33 Prozent nachbörslich ab - Analysten warnen vor tieferem Absturz! Was ist da los?Molina Healthcare hat eine schwache Prognose für... ► Artikel lesen | |
| VERU | 2,340 | +4,46 % | Veru Inc.: Veru to Report Fiscal 2026 First Quarter Financial Results on February 11th | ||
| CLOVER HEALTH INVESTMENTS | 1,781 | -1,38 % | Clover Health Investments, Corp.: Clover Health Announces Chelsea Clinton to Step Down from Board Following Eight Years of Service | WILMINGTON, Del., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover," "Clover Health" or the "Company") today announced that Chelsea Clinton, the longest-serving... ► Artikel lesen | |
| SOMNIGROUP INTERNATIONAL | 81,00 | -0,61 % | Somnigroup International: Somnigroup Proposes to Acquire Leggett & Platt in All-Stock Transaction | Proposal represents 30.3% premium to the average closing price of Leggett & Platt's shares during the last 30 trading days
Combination would provide Leggett &... ► Artikel lesen | |
| SHL TELEMEDICINE | - | - | Loyens & Loeff unterstützt SHL Telemedicine bei Kapitalerhöhung | ||
| SINTX TECHNOLOGIES | 2,940 | +3,16 % | SiNtx Technologies, Inc.: SINTX Technologies unterzeichnet Liefervertrag mit EVONIK zur Herstellung eines Siliziumnitrid-PEEK-Verbundwerkstoffes für KI-gestützte, 3D-gedruckte patientenspezifische Implantate | Ein Meilenstein, der die sofortige Produktion von maßgefertigten SiN/PEEK-Implantaten ermöglichtSALT LAKE CITY, Utah, Dec. 01, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX"... ► Artikel lesen | |
| NEURONETICS | 1,282 | -2,58 % | Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan | Delivered $37.3 million total revenue in Q3 2025, representing 11% adjusted pro forma revenue growth versus Q3 2024 Generated Greenbrook clinic revenue of $21.8 million in Q3 2025, an increase of... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 41,400 | -2,82 % | HV-Termine: Hauptversammlungen bei Adv. Blockchain, Aurubis, Fortec, Schott, Siemens, Healthineers, Stabilus, TUI | Einmal jährlich müssen sich Aufsichtsrat und Vorstand einer Gesellschaft den Aktionären stellen: Die Hauptversammlung ist das höchste Organ einer Aktiengesellschaft und vergleichbarer Unternehmens-Formen.... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,640 | +0,40 % | Fresenius Medical Care: Ein Neuanfang nach turbulenten Zeiten? | ||
| FRESENIUS | 49,760 | +1,06 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Fresenius mit einem Kursziel von 55 Euro auf "Buy" belassen. Die Bad Homburger seien in Verjüngungskur, und der Markt preise... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 28,740 | +4,89 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 39,680 | +3,44 % | BrightSpring Health Services, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026 | ||
| CARL ZEISS MEDITEC | 27,520 | +0,66 % | BARCLAYS stuft CARL ZEISS MEDITEC AG auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Carl Zeiss Meditec von 49 auf 32 Euro gesenkt und die Aktien von "Overweight" auf "Equal Weight" abgestuft. Nur... ► Artikel lesen |